Akeso Biomedical, Inc. — Form D

Akeso Biomedical, Inc. of Burlington, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-06. The offering totals $200K, of which $25K was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Robert Calvin GoforthDirectorFayetteville, AR
Greg W LeeDirectorFayetteville, AR
Kevin Calvin OhashiDirectorFayetteville, AR
Scott J RothDirectorFayetteville, AR
Anthony J SinskeyDirectorFayetteville, AR
Simon WilliamsDirectorSt Peter Port, Y7
Simon WilliamsExecutive OfficerSt Peter Port, Y7
Scott Calvin RothDirectorFayetteville, AR
Simon Calvin WilliamsDirectorFayetteville, AR
Simon Calvin WilliamsExecutive OfficerFayetteville, AR
Greg Calvin LeeDirectorFayetteville, AR
Anthony Calvin SinskeyDirectorFayetteville, AR
R. CALVIN GOFORTHDirectorFAYETTEVILLE, AR
Simon W WilliamsDirectorBurlington, MA
Simon W WilliamsExecutive OfficerBurlington, MA
Anthony W SinskeyDirectorBoston, MA
Scott W RothDirectorBurlington, MA
Kevin W OhashiDirectorFayetteville, AR
Mark W WagstaffExecutive OfficerFayetteville, AR
Bernard W PrusaczykDirectorWaltham, MA
Mark Calvin KiddExecutive OfficerFayetteville, AR
Bernard Calvin PrusaczykDirectorWaltham, MA
Bernard Calvin PrusaczykExecutive OfficerWaltham, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2021-02-12D$1.0M$574K
2019-11-08D$3.0M$597K
2018-12-05D/A$2.5M$982K
2018-05-18D$1.1M$149K
2017-03-17D/A$5.0M$2.5M
2016-03-23D$5.0M
2015-07-13D$1.0M$535K
2014-12-22D$500K$225K
2014-04-02D$250K

More